Cognitive dysfunction in severe chronic obstructive pulmonary disease (COPD) with or without Long-Term Oxygen Therapy...

Area of Science:

• Pulmonary Medicine
• Neurology
• Gerontology

Background:

• Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory illness.
• COPD can lead to cognitive dysfunction as a comorbidity.
• The impact of supplemental oxygen on COPD-related cognitive decline is under-researched.

Purpose of the Study:

• To compare cognitive function in hypoxemic COPD patients receiving long-term oxygen therapy (LTOT) versus those using oxygen as needed (AN).
• To evaluate the effectiveness of LTOT in preventing cognitive deterioration in COPD patients.
• To establish normal reference values for cognitive function in this population.

Main Methods:

• Assessed lung function, blood gases, health status, and cognitive function in 146 hypoxemic COPD patients.
• Utilized psychometric tests (MMSE, Clock test, TMT-A, TMT-B) to assess various cognitive domains.
• Compared 73 LTOT patients with 73 AN patients using t-tests and ANOVA.

Main Results:

• All COPD patients exhibited poorer cognitive function compared to normal controls.
• LTOT patients showed a lower prevalence and extent of severe cognitive deterioration, particularly in visual processing and executive functions (TMT-A, TMT-B).
• Cognitive domains like memory and attention (MMSE, Clock test) were less affected.

Conclusions:

• Long-term oxygen therapy (LTOT) is crucial for preserving cognitive functions in COPD patients.
• LTOT significantly mitigates COPD-induced cognitive decline.
• Patients prescribed LTOT should be informed about the cognitive benefits and risks associated with their condition.